Global spinal cord trauma market to grow at 3.7% CAGR through 2025: 5 observations

Spinal Tech

The global spinal cord trauma market is set to grow at a 3.7 percent compound annual growth rate through 2025, according to a Market Research Reports Search Engine analysis.

Here are five observations:

 

1. Nerve cell growth therapy will serve as a driver for the global market.

 

2. The partial spinal cord injury sector will likely grow at a higher rate than the complete SCI segment.

 

3. Hospitals accounted for a 53.2 percent market share in 2017, but will likely drop to 52.5 percent by 2025.

 

4. Road accidents and crime will drive spinal cord trauma treatment market in the Asia-Pacific area.

 

5. Bioaxone Biosciences, Acorda Therapeutics, Kringle Pharma, Pfizer, Novartis, Vertex Pharmaceuticals, InVivo Therapeutics, BioArctic, Asterias Biotherapeutics, Pharmicell, ReNetX Bio and BioTime will lead the market.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.